A citation-based method for searching scientific literature

Antonino Tuttolomondo, Anna Cirrincione, Alessandra Casuccio, Alessandro Del Cuore, Mario Daidone, Tiziana Di Chiara, Domenico Di Raimondo, Vittoriano Della Corte, Carlo Maida, Irene Simonetta, Stefania Scaglione, Antonio Pinto. Cardiovasc Diabetol 2021
Times Cited: 5







List of co-cited articles
7 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
40

Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.
Thomas Nyström, Mark K Gutniak, Qimin Zhang, Fan Zhang, Jens Juul Holst, Bo Ahrén, Ake Sjöholm. Am J Physiol Endocrinol Metab 2004
492
40

An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus.
Daniel S Hsia, Owen Grove, William T Cefalu. Curr Opin Endocrinol Diabetes Obes 2017
96
40

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
40

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
40

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
40

Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease.
Paula L McClean, Victor A Gault, Patrick Harriott, Christian Hölscher. Eur J Pharmacol 2010
137
20

Vascularization pattern after ischemic stroke is different in control versus diabetic rats: relevance to stroke recovery.
Roshini Prakash, Weiguo Li, Zhi Qu, Maribeth A Johnson, Susan C Fagan, Adviye Ergul. Stroke 2013
84
20

Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome.
Tracey A Baird, Mark W Parsons, Thanh Phan, Ken S Butcher, Patricia M Desmond, Brian M Tress, Peter G Colman, Brian R Chambers, Stephen M Davis. Stroke 2003
396
20

Treatment with exenatide in acute ischemic stroke trial protocol: A prospective, randomized, open label, blinded end-point study of exenatide vs. standard care in post stroke hyperglycemia.
Claire Muller, N Wah Cheung, Helen Dewey, Leonid Churilov, Sandy Middleton, Vincent Thijs, Elif I Ekinci, Chris Levi, Richard Lindley, Geoffrey Donnan,[...]. Int J Stroke 2018
9
20



Functions and dysfunctions of neocortical inhibitory neuron subtypes.
Ryoma Hattori, Kishore V Kuchibhotla, Robert C Froemke, Takaki Komiyama. Nat Neurosci 2017
56
20

Adult Neurogenesis in the Subventricular Zone and Its Regulation After Ischemic Stroke: Implications for Therapeutic Approaches.
Yörg Dillen, Hannelore Kemps, Pascal Gervois, Esther Wolfs, Annelies Bronckaers. Transl Stroke Res 2020
22
20

Vascular endothelial growth factor promotes pericyte coverage of brain capillaries, improves cerebral blood flow during subsequent focal cerebral ischemia, and preserves the metabolic penumbra.
Anil Zechariah, Ayman ElAli, Thorsten R Doeppner, Fengyan Jin, Mohammad R Hasan, Iris Helfrich, Günter Mies, Dirk M Hermann. Stroke 2013
86
20

GLP-1 receptor agonists in diabetes for stroke prevention: a systematic review and meta-analysis.
Konark Malhotra, Aristeidis H Katsanos, Vaia Lambadiari, Nitin Goyal, Lina Palaiodimou, Maria Kosmidou, Christos Krogias, Andrei V Alexandrov, Georgios Tsivgoulis. J Neurol 2020
6
20

The ARRIVE guidelines 2.0: updated guidelines for reporting animal research.
Nathalie Percie du Sert, Viki Hurst, Amrita Ahluwalia, Sabina Alam, Marc T Avey, Monya Baker, William J Browne, Alejandra Clark, Innes C Cuthill, Ulrich Dirnagl,[...]. J Physiol 2020
65
20

Insulin resistance and clinical outcomes after acute ischemic stroke.
Tetsuro Ago, Ryu Matsuo, Jun Hata, Yoshinobu Wakisaka, Junya Kuroda, Takanari Kitazono, Masahiro Kamouchi. Neurology 2018
31
20

Angiogenic recruitment of pericytes from bone marrow after stroke.
Erzsebet Kokovay, Lu Li, Lee A Cunningham. J Cereb Blood Flow Metab 2006
100
20


The glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia.
Fangzhe Chen, Weifeng Wang, Hongyan Ding, Qi Yang, Qiang Dong, Mei Cui. J Neuroinflammation 2016
22
20

ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020.
Elliott Lilley, S Clare Stanford, David E Kendall, Stephen P H Alexander, Giuseppe Cirino, James R Docherty, Christopher H George, Paul A Insel, Angelo A Izzo, Yong Ji,[...]. Br J Pharmacol 2020
209
20

Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology.
Steve P H Alexander, Richard E Roberts, Brad R S Broughton, Christopher G Sobey, Christopher H George, S Clare Stanford, Giuseppe Cirino, James R Docherty, Mark A Giembycz, Daniel Hoyer,[...]. Br J Pharmacol 2018
281
20

Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats.
Vladimer Darsalia, Shiva Mansouri, Henrik Ortsäter, Anna Olverling, Nino Nozadze, Camilla Kappe, Kerstin Iverfeldt, Linda M Tracy, Nina Grankvist, Åke Sjöholm,[...]. Clin Sci (Lond) 2012
100
20


Glucagon-like receptor 1 agonists and DPP-4 inhibitors: Anti-diabetic drugs with anti-stroke potential.
Vladimer Darsalia, Thomas Klein, Thomas Nyström, Cesare Patrone. Neuropharmacology 2018
27
20

Transient calretinin expression defines early postmitotic step of neuronal differentiation in adult hippocampal neurogenesis of mice.
Moritz D Brandt, Sebastian Jessberger, Barbara Steiner, Golo Kronenberg, Katja Reuter, Anika Bick-Sander, Wolfger von der Behrens, Gerd Kempermann. Mol Cell Neurosci 2003
357
20

Obesity-induced type 2 diabetes impairs neurological recovery after stroke in correlation with decreased neurogenesis and persistent atrophy of parvalbumin-positive interneurons.
Hiranya Pintana, Grazyna Lietzau, Ingrid Lovise Augestad, Fausto Chiazza, Thomas Nyström, Cesare Patrone, Vladimer Darsalia. Clin Sci (Lond) 2019
9
20

Global estimates of the prevalence of diabetes for 2010 and 2030.
J E Shaw, R A Sicree, P Z Zimmet. Diabetes Res Clin Pract 2010
20

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.
Adrian F Hernandez, Jennifer B Green, Salim Janmohamed, Ralph B D'Agostino, Christopher B Granger, Nigel P Jones, Lawrence A Leiter, Anne E Rosenberg, Kristina N Sigmon, Matthew C Somerville,[...]. Lancet 2018
634
20

Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Aidin Rawshani, Araz Rawshani, Stefan Franzén, Naveed Sattar, Björn Eliasson, Ann-Marie Svensson, Björn Zethelius, Mervete Miftaraj, Darren K McGuire, Annika Rosengren,[...]. N Engl J Med 2018
437
20

PDGFR-β as a positive regulator of tissue repair in a mouse model of focal cerebral ischemia.
Jie Shen, Yoko Ishii, Guihua Xu, Thanh Chung Dang, Takeru Hamashima, Takako Matsushima, Seiji Yamamoto, Yuichi Hattori, Yusuke Takatsuru, Junichi Nabekura,[...]. J Cereb Blood Flow Metab 2012
70
20

Glucagon-like peptide-1 receptor agonists as neuroprotective agents for ischemic stroke: a systematic scoping review.
Mark P Maskery, Christian Holscher, Stephanie P Jones, Christopher I Price, W David Strain, Caroline L Watkins, David J Werring, Hedley Ca Emsley. J Cereb Blood Flow Metab 2021
8
20

Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project.
Salah-Eddine Megherbi, Chantal Milan, Dominique Minier, Grégory Couvreur, Guy-Victor Osseby, Kate Tilling, Antonio Di Carlo, Domenico Inzitari, Charles D A Wolfe, Thibault Moreau,[...]. Stroke 2003
238
20

Association of glucagon-like peptide-1 receptor agonist use and rates of acute myocardial infarction, stroke and overall mortality in patients with type 2 diabetes mellitus in a large integrated health system.
Robert S Zimmerman, Todd M Hobbs, Brian J Wells, Sheldon X Kong, Michael W Kattan, Jon Bouchard, Kevin M Chagin, Changhong Yu, Brian Sakurada, Alex Milinovich,[...]. Diabetes Obes Metab 2017
14
20

The diabetes drug semaglutide reduces infarct size, inflammation, and apoptosis, and normalizes neurogenesis in a rat model of stroke.
Xiaoyan Yang, Peng Feng, Xiangjian Zhang, Dongfang Li, Ruifang Wang, Chenhui Ji, Guanglai Li, Christian Hölscher. Neuropharmacology 2019
22
20

The Stroke-Induced Increase of Somatostatin-Expressing Neurons is Inhibited by Diabetes: A Potential Mechanism at the Basis of Impaired Stroke Recovery.
Fausto Chiazza, Hiranya Pintana, Grazyna Lietzau, Thomas Nyström, Cesare Patrone, Vladimer Darsalia. Cell Mol Neurobiol 2021
2
50

Neuroprotective Mechanisms of Glucagon-like Peptide-1-based Therapies in Ischaemic Stroke: A Systematic Review based on Pre-Clinical Studies.
Ida R Marlet, Joakim N E Ölmestig, Tina Vilsbøll, Jørgen Rungby, Christina Kruuse. Basic Clin Pharmacol Toxicol 2018
24
20

The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway.
Fausto Chiazza, Harald Tammen, Hiranya Pintana, Grazyna Lietzau, Massimo Collino, Thomas Nyström, Thomas Klein, Vladimer Darsalia, Cesare Patrone. Cardiovasc Diabetol 2018
33
20

Glucagon-Like Peptide-1 Receptor Agonists and Prevention of Stroke Systematic Review of Cardiovascular Outcome Trials With Meta-Analysis.
Giuseppe Bellastella, Maria Ida Maiorino, Miriam Longo, Lorenzo Scappaticcio, Paolo Chiodini, Katherine Esposito, Dario Giugliano. Stroke 2020
14
20

Type 2 diabetes-induced neuronal pathology in the piriform cortex of the rat is reversed by the GLP-1 receptor agonist exendin-4.
Grazyna Lietzau, Thomas Nyström, Claes-Göran Östenson, Vladimer Darsalia, Cesare Patrone. Oncotarget 2016
21
20


Delayed Administration of the Glucagon-Like Peptide 1 Analog Liraglutide Promoting Angiogenesis after Focal Cerebral Ischemia in Mice.
Yanxia Chen, Xiangjian Zhang, Junna He, Yanzhao Xie, Yang Yang. J Stroke Cerebrovasc Dis 2018
13
20


Early loss of pericytes and perivascular stromal cell-induced scar formation after stroke.
Francisco Fernández-Klett, Jason R Potas, Diana Hilpert, Katja Blazej, Josefine Radke, Jojanneke Huck, Odilo Engel, Werner Stenzel, Guillem Genové, Josef Priller. J Cereb Blood Flow Metab 2013
122
20

The effect of insulin resistance on inflammatory response and oxidative stress in acute cerebral ischemia.
Ayca Ozkul, Mediha Ayhan, Ali Akyol, Eylem Telli Turgut, Gurhan Kadikoylu, Cigdem Yenisey. Neuro Endocrinol Lett 2013
9
20

Protective effect of rhGLP-1 (7-36) on brain ischemia/reperfusion damage in diabetic rats.
Libo Zhao, Jia Xu, Qian Wang, Zhonglian Qian, Wanyu Feng, Xiaoxing Yin, Yi Fang. Brain Res 2015
19
20

Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.
J B Bederson, L H Pitts, M Tsuji, M C Nishimura, R L Davis, H Bartkowski. Stroke 1986
20

Modulation of hippocampal neural plasticity by glucose-related signaling.
Marco Mainardi, Salvatore Fusco, Claudio Grassi. Neural Plast 2015
42
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.